Grantham, Mayo, Van Otterloo & Co (GMO)’s Nasdaq NDAQ Stock Holding History
Bought
Maintained
Sold
Other funds holding NDAQ
IA
Grantham, Mayo, Van Otterloo & Co (GMO)'s NDAQ Position: Q2 2025 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Nasdaq (NDAQ) in Q2 2025, closing a stake of 7,487 shares — an estimated $568K sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NDAQ in Q2 2013 and held it in 27 quarters. The position peaked at $51.2M in Q2 2016. 1,018 funds tracked by Wall St. Rank hold NDAQ as of Q2 2025.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Nasdaq position as of Q2 2025 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 7,487 Nasdaq shares in Q2 2025, an estimated $568K.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Nasdaq in Q2 2013 and held it in 27 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Nasdaq position peaked at $51.2M in Q2 2016.
- 1,018 funds tracked by Wall St. Rank held Nasdaq as of Q2 2025.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2025, filed 13 Aug 2025.